PL2254598T3 - Połączenie agonistów receptorów nikotynowych alfa 7 i środków przeciwpsychotycznych - Google Patents

Połączenie agonistów receptorów nikotynowych alfa 7 i środków przeciwpsychotycznych

Info

Publication number
PL2254598T3
PL2254598T3 PL09709577T PL09709577T PL2254598T3 PL 2254598 T3 PL2254598 T3 PL 2254598T3 PL 09709577 T PL09709577 T PL 09709577T PL 09709577 T PL09709577 T PL 09709577T PL 2254598 T3 PL2254598 T3 PL 2254598T3
Authority
PL
Poland
Prior art keywords
antipsychotics
alpha
combination
nicotinic agonists
nicotinic
Prior art date
Application number
PL09709577T
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Terry Hauser
Kristen G Jordan
Sharon R Letchworth
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of PL2254598T3 publication Critical patent/PL2254598T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL09709577T 2008-02-13 2009-02-13 Połączenie agonistów receptorów nikotynowych alfa 7 i środków przeciwpsychotycznych PL2254598T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
PCT/US2009/034062 WO2009102962A2 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics
EP09709577.2A EP2254598B1 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics

Publications (1)

Publication Number Publication Date
PL2254598T3 true PL2254598T3 (pl) 2013-12-31

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09709577T PL2254598T3 (pl) 2008-02-13 2009-02-13 Połączenie agonistów receptorów nikotynowych alfa 7 i środków przeciwpsychotycznych

Country Status (25)

Country Link
US (1) US20110059947A1 (pl)
EP (2) EP2254598B1 (pl)
JP (1) JP2011511845A (pl)
KR (1) KR20100113163A (pl)
CN (2) CN101977628A (pl)
AU (1) AU2009214625A1 (pl)
BR (1) BRPI0907570A2 (pl)
CA (1) CA2715268A1 (pl)
CO (1) CO6290706A2 (pl)
CY (1) CY1114492T1 (pl)
DK (1) DK2254598T3 (pl)
EC (1) ECSP10010471A (pl)
ES (1) ES2430622T3 (pl)
HR (1) HRP20130749T1 (pl)
IL (1) IL207389A0 (pl)
MX (1) MX2010008875A (pl)
NZ (1) NZ587312A (pl)
PL (1) PL2254598T3 (pl)
PT (1) PT2254598E (pl)
RS (1) RS52941B (pl)
RU (1) RU2481123C2 (pl)
SG (1) SG188144A1 (pl)
SI (1) SI2254598T1 (pl)
WO (1) WO2009102962A2 (pl)
ZA (1) ZA201005999B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
KR20130108586A (ko) 2010-09-23 2013-10-04 애브비 인코포레이티드 아자아다만탄 유도체의 일수화물
CN103442711A (zh) * 2011-01-18 2013-12-11 塔加西普特公司 精神分裂症中的认知功能障碍的治疗方法
US9139576B2 (en) 2011-05-03 2015-09-22 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
CA2886010A1 (en) * 2012-10-02 2014-04-10 Sumitomo Dainippon Pharma Co., Ltd. Imidazole derivative
JP6807094B2 (ja) * 2016-04-29 2021-01-06 国立大学法人秋田大学 クロザピン又はその誘導体の血中薬剤濃度上昇リスク判定方法及び薬剤投与量判定方法
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
PL3810100T3 (pl) 2018-06-20 2025-05-12 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
JP2024502474A (ja) 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Ｓｔｉｎｇ活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
US20240308978A1 (en) * 2021-01-08 2024-09-19 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
EP1083889B1 (en) 1998-06-01 2003-12-10 Ortho-McNeil Pharmaceutical, Inc. Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
IL149669A0 (en) * 1999-12-10 2002-11-10 Wyeth Corp NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
US6916828B2 (en) 2000-06-27 2005-07-12 Laboratorios S.A.L.V.A.T., S.A. Carbamates derivatived from arylakylamines
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
WO2002016357A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
WO2002016356A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
AU2001282910A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
RU2296762C2 (ru) 2000-12-22 2007-04-10 Альмиралль Продесфарма Аг Карбаматы хинуклидина, способы их получения и фармацевтическая композиция на их основе
EP1476448A2 (en) * 2002-02-19 2004-11-17 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds for the treatment of disease
BR0317019A (pt) * 2002-12-06 2005-10-25 Pharmacia & Upjohn Co Llc Sais cristalinos fumarato de 1-azabiciclo[2.2.2]oct-substituìdo-furo[2,3-c]piridinil- carboxamida e suas composições e preparações
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
MXPA06007213A (es) * 2003-12-23 2006-08-18 Pfizer Prod Inc Combinacion terapeutica para la mejora de la cognicion y trastornos sicoticos.
CA2601509A1 (en) * 2005-03-18 2006-09-28 Abbott Laboratories Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions

Also Published As

Publication number Publication date
NZ587312A (en) 2011-12-22
ES2430622T3 (es) 2013-11-21
EP2633868A1 (en) 2013-09-04
HK1147954A1 (en) 2011-08-26
RS52941B (sr) 2014-02-28
RU2481123C2 (ru) 2013-05-10
ECSP10010471A (es) 2010-10-30
WO2009102962A2 (en) 2009-08-20
WO2009102962A3 (en) 2009-10-08
CY1114492T1 (el) 2016-10-05
IL207389A0 (en) 2010-12-30
MX2010008875A (es) 2010-08-31
EP2254598A2 (en) 2010-12-01
ZA201005999B (en) 2011-05-25
RU2010137787A (ru) 2012-03-20
JP2011511845A (ja) 2011-04-14
EP2254598B1 (en) 2013-07-10
PT2254598E (pt) 2013-10-16
HRP20130749T1 (en) 2013-10-11
CN103143023A (zh) 2013-06-12
KR20100113163A (ko) 2010-10-20
AU2009214625A1 (en) 2009-08-20
CN101977628A (zh) 2011-02-16
SI2254598T1 (sl) 2013-10-30
BRPI0907570A2 (pt) 2019-09-24
SG188144A1 (en) 2013-03-28
US20110059947A1 (en) 2011-03-10
CO6290706A2 (es) 2011-06-20
CA2715268A1 (en) 2009-08-20
DK2254598T3 (da) 2013-07-29

Similar Documents

Publication Publication Date Title
ZA201005999B (en) Combination of alpha 7 nicotinic agonists and antipsychotics
PL2134330T3 (pl) Kombinacje odwrotnych agonistów i antagonistów 5-HT2A z antypsychotykami
ZA201103044B (en) Conjugates of glp-1 agonists and uses thereof
ZA201003625B (en) 5-anilinoimidazopyridines and methods of use
ZA200906062B (en) Benzimidazole derivatives and methods of use thereof
ZA201008483B (en) Diazacarbazoles and methods of use
IL209282A0 (en) Heterocyclic compound and use thereof
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
IL206125A0 (en) Azaindolizines and methods of use
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
IL209548A0 (en) Diazacarbazoles and methods of use
PL2376101T3 (pl) Elektory beta-arestyny oraz ich kompozycje i sposoby stosowania
IL208771A0 (en) Iminopyridine derivatives and use thereof
IL205207A0 (en) Benzimidazole derivatives and their use as fxr agonists
ZA201004894B (en) Nuctraceutical composition and methods of use
PL2366013T3 (pl) Kompozycje do prania i sposoby ich zastosowania
ZA201004893B (en) Nuctraceutical composition and methods of use
GB2461611B (en) Composition and use thereof
ZA201007681B (en) Cd4-related polypeptides and methods of use
IL209545A0 (en) Substotited pyrroles and methods of use
SI2134330T1 (sl) Kombinacije 5-HT2A inverznih agonistov in antagonistov z antipsihotiki
IL205998A0 (en) Compositions comprising nicotinic agonists and methods of using same
GB0808877D0 (en) Composition and use thereof
GB0810409D0 (en) Composition and use thereof